Biotech

All Articles

GSK's long-acting bronchial asthma medicine halved assaults in stage 3

.GSK's long-acting breathing problem treatment has been presented to cut in half the number of strik...

AstraZeneca, Daiichi unbox Dato-DXd's general survival stop working

.AstraZeneca and Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has actually fallen s...

Roivant reveals brand-new 'vant' to progress Bayer high blood pressure med

.Matt Gline is actually back with a brand-new 'vant' provider, after the Roivant Sciences chief exec...

Viridian eye health condition phase 3 hits, evolving push to competing Amgen

.Viridian Rehabs' period 3 thyroid eye ailment (TED) clinical trial has struck its key as well as su...

Bain reveals $3B fund forever science providers

.With a tough track record for determining rough diamonds, Bain Capital Life Sciences (BCLS) has bec...

Genentech's cancer cells restructure brought in 'for clinical reasons'

.The recent decision to merge Genentech's 2 cancer cells divisions was actually created "scientific ...

Tern dental GLP-1 reveals 5% weight-loss at 1 month at highest possible dosage

.Terns Pharmaceuticals' decision to fall its liver ailment aspirations may however pay, after the bi...

Merck, Daiichi repeat early success in small mobile lung cancer along with upgraded ADC data

.Merck &amp Co.'s long-running attempt to land a hit on little tissue lung cancer (SCLC) has acquire...

Boehringer, Bayer advance lung cancer medicines towards Astra battle

.Some patients along with non-small tissue lung cancer cells (NSCLC) possess anomalies in a gene nam...

MBX pursues $136M IPO to take opponent to Ascendis into stage 3

.MBX has elaborated plannings to enjoy over $136 million from its own IPO as the biotech hopes to br...